|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Adaptation of HIV-1to human leukocyte antigen class I显示文摘 | Kawashima Y Pfafferott K Frater J Matthews P Payne R Addo M Gatanaga H Fujiwara M Hachiya A Koizumi H Kuse N Oka S Duda A Prendergast A Crawford H Leslie A Brumme Z Brumme C Allen T Brander C Kaslow R Tang J Hunter E Allen S Mulenga J Branch S Roach T John M Mallal S Ogwu A Shapiro R Prado J G Fidler S Weber J Pybus O G Klenerman P Ndung'u T Phillips R Heckerman D Harrigan P R Walker B D Takiguchi M Goulder P | 2009 | Nature2009，458，7238： | 1 |
| 2 | Chronic hyperlactatemia in HIV-infected patients taking antiretroviral therapy显示文摘 | Mina John Corey B. Moore Ian R. James David Nolan Richard P. Upton Elizabeth J. McKinnon Simon A. Mallal | 2001 | AIDS2001，，6： | 1 |
| 3 | HLA-B * 5701 screening for hypersensitivity to abacavir 显示文摘 | Mallal S Phillips E Carosi G or the PREDICT-1 Study Team | 2008 | N Engl J Med2008，358，： | 1 |
| 4 | Transmission and accumulation of CTL escape variants drive negative associations between HIV polymorphisms and HLA显示文摘 | Leslie A Kavanagh D Honeyborne I Pfafferott K Edwards C Pillay T Hilton L Thobakgale C Ramduth D Draenert R Le Gall S Luzzi G Edwards A Brander C Sewell A K Moore S Mullins J Moore C Mallal S Bhardwaj N Yusim K Phillips R Klenerman P Korber B Kiepiela P Walker B Goulder P | 2005 | J Exp Med2005，201，6： | 1 |
| 5 | Correlates of protective cellular immunity revealed by analysis of population-level immune escape pathways in HIV-1显示文摘 | Carlson J M Brumme C J Martin E Listgarten J Brockman M A Le A Q Chui C K Cotton L A Knapp D J Riddler S A Haubrich R Nelson G Pfeifer N Deziel C E Heckerman D Apps R Carrington M Mallal S Harrigan P R John M Brumme Z L International HIV Adaptation Collaborative | 2012 | J Virol2012，86，13： | 1 |
| 6 | Association between pres- ence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hy- persensitivity to HIV-1 reverse-transcriptase inhibitor aba- cavir显示文摘 | Mallal S Nolan D Witt C | 2002 | Lancet2002，359，9308： | 1 |
| 7 | Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase in- hibitor abacavir显示文摘 | Mallal S Nolan D Witt C | 2002 | Lancet2002，359，9308： | 1 |
| 8 | Drug hypersensitivity in HIV显示文摘 | Phillips E Mallal S | | 0，，： | 1 |
| 9 | Pharmacogenetics of drug hypersen - sltivity显示文摘 | PHILLIP E J MALLAL SA | 2010 | Pharmacogenomics2010，11，7： | 1 |
| 10 | Complications associated with NRTI therapy: update on clinical features and possible pathogenic mechanisms 显示文摘 | Nolan D Mallal S | 2004 | Antivir Ther2004，9，： | 1 |
| 11 | Association between presence ofHLA-B*5701,HLA-DR7,and HLA-DQ3 and hypersensitivi-ty to HIV-1 reverse-transcriptase inhibitor abacavir显示文摘 | Mallal S Nolan D Witt C | 2002 | Lan-cet2002，359，： | 1 |
| 12 | HLA-B*5701screening forhypersensitivity to abacavir显示文摘 | Mallal S Phillips E Carosi G | 2008 | N Engl J Med2008，358，： | 1 |
| 13 | Trends in incidence of AIDS illnesses in Australia from 1983 to 1994:the Australian AIDS cohort 显示文摘 | Dore GJ Hoy JF Mallal SA | 1997 | J Acquit Immune Defic Syndr Hum Retrovirol1997，16，1： | 1 |
| 14 | Association between presenceof HLA-B*5701,HLA-DR7,and HLA-DQ3 and hypersensiti-vity to HIV-1 reverse-transcriptase inhibitor abacavir显示文摘 | Mallal S Nolan D Witt C | 2002 | Lancet2002，359，9308： | 1 |
| 15 | HLA-B*5701screening for hypersensitivity to abacavir显示文摘 | Mallal S Phillips E Carosi G | | 0，，： | 1 |
| 16 | Complications associated with NRTI therapy: up- date on clinical features and possible pathogenic mechanisms显示文摘 | Nolan D Mallal S | 2004 | Antivir Ther2004，9，： | 1 |
| 17 | HLA-B*5701 screen- ing for hypersensitivity to abacavir显示文摘 | Mallal S Phillips E Carosi G | 2008 | N Engl J Med2008，358，6： | 1 |
| 18 | HLA-B*5701 screening for hypersensitivity to abacavir显示文摘 | Mallal S Phillips E Carosi G | 2008 | N Engl J Med2008，358，6： | 1 |
| 19 | HLA-B * 5701 screening for hypersensitivity to abacavir 显示文摘 | Mallal S Phillips E Carosi G | 2008 | N Engl J Med2008，358，6： | 1 |
| 20 | Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-I reverse-transcriptase inhibitor abacavir 显示文摘 | Mallal S Nolan D Witt C | 2002 | Lancet2002，359，9308： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员